Lipocine
LPCN
#10631
Rank
โ‚ฌ15.53 M
Marketcap
1,88ย โ‚ฌ
Share price
2.88%
Change (1 day)
-35.75%
Change (1 year)

EPS for Lipocine (LPCN)

EPS in 2026 (TTM): -1,64ย โ‚ฌ

According to Lipocine's latest financial reports the company's current EPS (TTM) is -1,66ย โ‚ฌ. In 2025 the company made an earnings per share (EPS) of -1,56ย โ‚ฌ a decrease over its 2024 EPS that were of N/A.

EPS history for Lipocine from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-1,64ย โ‚ฌ5.29%
2025-1,56ย โ‚ฌ
2024N/A-100%
2023-2,73ย โ‚ฌ51.96%
2022-1,80ย โ‚ฌ1100%
2021-0,15ย โ‚ฌ-97.37%
2020-5,69ย โ‚ฌ-24%
2019-7,48ย โ‚ฌ-9.09%
2018-8,23ย โ‚ฌ-47.62%
2017-15,71ย โ‚ฌ0.96%
2016-15,56ย โ‚ฌ87.39%
2015-8,31ย โ‚ฌ-65.31%
2014-23,94ย โ‚ฌ11.11%
2013-21,55ย โ‚ฌ-28%
2012-29,93ย โ‚ฌ1061.88%
2011-2,58ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Seagen
SGEN
-3,53ย โ‚ฌ 112.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Jazz Pharmaceuticals
JAZZ
0,40ย โ‚ฌ-124.34%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Agile Therapeutics
AGRX
-3,41ย โ‚ฌ 104.76%๐Ÿ‡บ๐Ÿ‡ธ USA